Skip to main content

Food Allergies Affect People of Color More than White People

A new study found that people of color have more food allergies than white people and that lower-income people are also more affected by food allergies. In general, food allergies affect 11% of adults and 8% of children, according to the study published in JAMA Network Open. Non-Hispanic white people across all ages had the lowest rate of food allergies at 9.5%, compared with people who are Asian, 10.5%; Hispanic, 10.6%; and non-Hispanic Blacks, 10.6%. The cause is probably not genetics, said Mahboobeh Mahdavinia, MD, with RUSH Medical College in Chicago, on CNN. “The majority of this is likely driven by the environment and the social economy factors that impact environments that people are born into and live in as adults,” said Mahdavinia, who was not involved in the study. “Exposure to certain microbes in the environment may affect the gut microbiome, the collection of bacteria that live in a person’s gastrointestinal tract,and that could leave someone susceptible to developing food allergies, Mahdavinia said. Food allergies can also be caused by pollution. “Research shows that people of color tend to live in more polluted neighborhoods, regardless of income,” CNN reported. Food allergies were lowest in households earning more than $150,000, at 8.3%, the study said. People with food allergies might face an allergy-related economic burden, poorer health, and an increased risk of conditions such as eczema and asthma, the study’s authors wrote. Researchers surveyed almost 52,000 households between October 9, 2015, and September 18, 2016.
Labels:

Comments

Post a Comment

Popular posts from this blog

Ignoring influenza and flu in winter can be Dangerous

Ignoring influenza (the flu) and flu-like symptoms during the winter can indeed be dangerous. Influenza is a viral infection that primarily spreads through respiratory droplets when an infected person coughs or sneezes. It tends to be more prevalent during the colder months, which is why it's often associated with winter. Here are some reasons why ignoring the flu in winter can be dangerous: Complications: The flu can lead to serious complications, especially in vulnerable populations such as young children, the elderly, pregnant women, and individuals with weakened immune systems. Complications can include pneumonia, bronchitis, sinus infections, and ear infections. Spread of the Virus: Influenza is highly contagious, and neglecting symptoms can contribute to the spread of the virus to others. This is particularly concerning in crowded places like schools, offices, and public transportation. Weakened Immune System: The winter season itself can weaken the immune system, making ...
Post a Comment
Read more

What Is a Secondary Headache?

A secondary headache is a type of headache that is a symptom of another underlying medical condition or disease. Unlike primary headaches, which are not associated with any underlying cause, secondary headaches are a result of an identifiable and usually serious underlying problem. There are numerous potential causes of secondary headaches, including: Head Injury: Traumatic head injuries can lead to headaches as a symptom. Sinusitis: Inflammation of the sinuses can cause pain and pressure in the head. Migraines: While migraines can be primary headaches, they can also be secondary if they are triggered by an underlying condition. Medication Overuse: Excessive use of pain medications, especially those containing caffeine or codeine, can lead to rebound headaches. Infection: Various infections, such as meningitis, encephalitis, or a sinus infection, can cause secondary headaches. High Blood Pressure: Hypertension (high blood pressure) can lead to headaches, especially if it is seve...
Post a Comment
Read more

FDA Approves Pfizer’s Vaccine for Meningococcal Disease

The U.S. Food and Drug Administration has approved Pfizer’s application for Penbraya, a vaccine for people 10 through 25 that will offer protection against the five main kinds of bacteria that cause meningitis and blood poisoning. The new drug will reduce the number of doses that people need to be fully vaccinated, Pfizer said in a news release. Penbraya will be given as a two-dose series administered six months apart, Pfizer said. Medical authorities currently recommend Trumenba for meningococcal group B and Nimenrix for meningococcal groups A, C, W-135, and Y, meaning people need four doses for full protection. “In a single vaccine, PENBRAYA has the potential to protect more adolescents and young adults from this severe and unpredictable disease by providing the broadest meningococcal coverage in the fewest shots,” Annaliesa Anderson, PhD, senior vice president and head of vaccine research and development for Pfizer, said in the release. Penbraya combines Trumenba, which is mad...
Post a Comment
Read more